Target intelligence / Profile preview

Golgi autoantigen, golgin subfamily A, 6-like 2 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

Golgi autoantigen, golgin subfamily A, 6-like 2 pseudogene (GOLGA6L2 pseudogene, ENSG00000205976) is identified as a pseudogene in the human genome[1]. Pseudogenes are genomic DNA sequences similar to normal genes but non-functional; they do not encode active proteins due to disabling mutations such as frameshifts, premature stop codons, or promoter disruptions[7]. Though most pseudogenes, including this locus, are not therapeutically actionable, some pseudogenes can regulate parental gene expression through various RNA-based mechanisms, including microRNA decoy activity, antisense regulation, fusion transcripts, or epigenetic modulation (as evidenced for other, but not this specific, pseudogenes)[3][5][7]. There is no evidence that ENSG00000205976 encodes a functional protein, serves as a therapeutic target, interacts with drugs, or is used as a biomarker. Its annotation is correct as a pseudogene, so it is not considered a molecular drug target, and its main relevance is for genomic annotation and potential RNA-level regulation in very specific contexts[1]. Critical Notes: - "GOLGA6L2 pseudogene" is correctly annotated as a pseudogene, not a protein-coding gene, nor is it a classical receptor, enzyme, or transporter[1]. - There is no canonical abbreviation in use for this pseudogene. - It is not associated with any therapeutic drug targeting or established role in disease mechanisms specific to this locus. - As a pseudogene, it is not a druggable target or a clinical biomarker, and no safety concerns are reported. - The entry is not a mistake or misspelling, but as a pseudogene, it is "incorrect" to treat it as a therapeutic or pharmacologically actionable protein target. Summary: This locus is a pseudogene, not a protein target, drug target, or a functional receptor/enzyme/transporter. There are no canonical abbreviations, drugs, mechanisms of action, or biomarkers associated with it. Its main significance lies in genome annotation and potential, but largely unproven, regulatory RNA functions.

Other names
GOLGA6L2 pseudogene
02

Biological functions

Potential post-transcriptional regulation (general pseudogene function)
03

Disease associations

Other (General potential involvement in gene regulation or disease via RNA-based mechanisms, but no direct evidence for this pseudogene)

Beyond the preview

Go deeper on Golgi autoantigen, golgin subfamily A, 6-like 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golgi autoantigen, golgin subfamily A, 6-like 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call